Cannabis Bioscience International Holdings, Inc.
CBIH · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -30.8% | 134.1% | -79.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -134.1% | 87% | -29.9% | 89.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -309% | -351.3% | -730.3% | -69.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -341.5% | -605.7% | -1,213.9% | -107.1% |
| EPS | -0.007 | -0.02 | -0.019 | -0.008 |
| % Growth | 64.1% | -6.5% | -144.7% | – |
| EPS Diluted | -0.007 | -0.02 | -0.019 | -0.008 |
| Weighted Avg Shares Out | 12 | 11 | 10 | 10 |
| Weighted Avg Shares Out Dil | 12 | 11 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | -$0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -187.9% | -197.3% | -1,004.3% | -95.4% |